The Model
Semiconservative replication — each new molecule has one old and one new strand
Watson and Crick noted in their 1953 paper that the complementary base pairing of the double helix 'immediately suggests a possible copying mechanism for the genetic material.' If the strands separate, each can serve as a template for synthesis of a new complementary strand — producing two double helices each identical to the original.
Three models were initially proposed: conservative (original helix stays together, new helix is entirely new), semiconservative (each daughter helix has one original strand and one new strand), and dispersive (old and new sequences are interspersed on both strands). The Meselson-Stahl experiment (1958) proved the semiconservative model using density labeling with heavy nitrogen (¹⁵N) — one of the most elegant experiments in biology.
💡 Telomeres — The End Replication Problem
DNA polymerase cannot replicate the very ends of linear chromosomes completely — when the RNA primer at the 5' end of the lagging strand is removed, there is no upstream 3'-OH to fill in the gap. This means chromosomes get slightly shorter with each round of replication — the 'end replication problem.'
Telomeres are repetitive sequences at chromosome ends (TTAGGG in humans, repeated ~2,500 times) that act as a buffer — they shorten with each division, protecting coding DNA from erosion. Normal somatic cells have limited replication capacity (~50 divisions = the Hayflick limit) before their telomeres are critically short → cells enter senescence or apoptosis.
Telomerase is a reverse transcriptase enzyme that extends telomeres using its own RNA template. It is active in: germline cells (to maintain telomere length across generations), stem cells, and most cancer cells. ~90% of human cancers reactivate telomerase — allowing unlimited replication (cellular immortality). Telomerase inhibitors are being developed as anti-cancer drugs. Normal somatic cells progressively shorten telomeres → aging → senescence.
Init
Initiation — the replication fork opens
Replication begins at specific DNA sequences called origins of replication (ori). Bacteria have one origin (oriC in E. coli); human chromosomes have thousands of origins (necessary because human chromosomes are so long). Initiator proteins bind the origin → recruit helicase (unwinds the double helix by breaking H-bonds) → two replication forks form and move in opposite directions (bidirectional replication) from the origin.
Single-strand binding proteins (SSBPs) stabilize the separated strands and prevent re-annealing. Topoisomerases (particularly DNA gyrase in bacteria, topoisomerase II in eukaryotes) relieve the positive supercoiling that forms ahead of the replication fork as helicase unwinds the DNA — if not relieved, the helix would tighten and halt replication.
Memory trick: Replication starts at origins. Helicase = unwind. SSBPs = keep strands apart. Topoisomerase = relieve tension ahead of the fork. Multiple origins in eukaryotes = faster replication of huge chromosomes.
Prim
Priming — RNA primers start each new strand
DNA polymerase cannot start synthesis from scratch — it can only extend an existing strand. An RNA primer (synthesized by the enzyme primase — an RNA polymerase) provides the free 3'-OH that DNA polymerase needs to begin extension. On the leading strand, one RNA primer is needed at the origin. On the lagging strand, a new RNA primer is needed for each Okazaki fragment.
After replication, RNA primers are removed (by RNase H and FEN1 in eukaryotes, or DNA Pol I in bacteria — which has 5'→3' exonuclease activity), the gaps are filled by DNA polymerase, and the nicks are sealed by DNA ligase.
Memory trick: Primase makes the RNA primer. DNA Pol needs a 3'-OH to start — the primer provides it. RNA primer = temporary starter. Later removed and replaced with DNA.
Elong
Elongation — leading and lagging strand synthesis
DNA polymerase synthesizes DNA only in the 5'→3' direction (adding nucleotides to the 3'-OH end of the growing strand). Since the two template strands are antiparallel, this creates an asymmetry at the replication fork:
Leading strand: synthesized continuously in the same direction as fork movement (5'→3' synthesis in the direction of fork advance). One primer, one continuous synthesis.
Lagging strand: must be synthesized in the direction away from fork movement (because its template runs 3'→5' in the direction of fork advance, but DNA pol can only synthesize 5'→3'). Synthesized in short Okazaki fragments (~100–200 nt in eukaryotes, ~1000–2000 nt in bacteria), each requiring its own RNA primer. After each fragment is made, the primer is removed, the gap is filled, and adjacent fragments are ligated together by DNA ligase.
Memory trick: Leading strand = continuous (flows with fork). Lagging strand = discontinuous Okazaki fragments (made opposite to fork direction, then joined). Both are synthesized 5'→3' — it's the template reading direction that differs.
Fidel
Fidelity — proofreading and repair
Raw error rate of DNA polymerase is ~1 per 10⁵ bases. After proofreading (DNA polymerase's 3'→5' exonuclease activity — it can excise a misincorporated nucleotide and replace it with the correct one): ~1 per 10⁷. After mismatch repair (recognizes mismatched base pairs in the newly synthesized strand and repairs them): ~1 per 10⁹–10¹⁰.
This extraordinary accuracy is essential. Human cells replicate ~6 billion base pairs each division. At 1 error per 10⁹, that's ~6 errors per division in every cell — a manageable number. Without proofreading, there would be thousands of mutations per cell division, rapidly destroying genomic integrity and causing cancer.
Memory trick: Raw error rate 1/10⁵ → proofreading → 1/10⁷ → mismatch repair → 1/10⁹. Each layer of correction reduces errors by ~100-fold. Proofreading = DNA Pol goes backwards to fix mistakes.
🔬 Applied Scenario — Replication Enzymes as Drug Targets
The enzymes of DNA replication are critical drug targets in cancer and infectious disease:
A
Topoisomerase inhibitors — cancer chemotherapy. Topoisomerases relieve the supercoiling that builds ahead of the replication fork. Topoisomerase I inhibitors (irinotecan, topotecan) trap topoisomerase I in a complex with DNA → single-strand nicks cannot be resealed → replication fork collides with the nick → double-strand break → cell death. Topoisomerase II inhibitors (etoposide, doxorubicin) trap topoisomerase II → double-strand breaks → cell death. These drugs are particularly effective against rapidly dividing cancer cells because they interfere with active replication.
B
Nucleoside analogs — HIV, hepatitis B, and herpes treatment. Many antiviral drugs are nucleoside analogs — modified nucleotides that are incorporated into viral DNA during replication but then block further extension (chain terminators). Zidovudine (AZT, first HIV drug) is a thymidine analog that lacks the 3'-OH → incorporated into viral DNA by HIV reverse transcriptase → no 3'-OH available for the next nucleotide → chain termination. Acyclovir (herpes) and tenofovir (HIV, hepatitis B) work similarly. The selectivity comes from viral polymerases incorporating the analogs more efficiently than host DNA polymerases.
C
PCNA and replication fork proteins as cancer biomarkers. Proliferating cell nuclear antigen (PCNA) is a sliding clamp that surrounds DNA and tethers DNA polymerase to the template, preventing dissociation. PCNA expression is a direct measure of cell proliferation — it is used in pathology as a proliferation marker for tumors (high PCNA staining = rapidly dividing tumor). Ki-67 (another replication-associated protein) is similarly used to grade tumor aggressiveness.
D
Mismatch repair deficiency and Lynch syndrome. Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC) results from germline mutations in DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2). Without mismatch repair, replication errors accumulate rapidly → microsatellite instability (MSI, detectable in tumor DNA as length changes in repetitive sequences) → colorectal, endometrial, and other cancers at young ages. Tumors with MSI respond particularly well to immune checkpoint inhibitors (pembrolizumab) — the high mutation load creates many neoantigens recognized by T cells.
📌 Exam Application
DNA replication is tested from molecular mechanisms to clinical applications:
1. Semiconservative model: Each daughter molecule has one parental and one new strand. Proved by Meselson-Stahl experiment (¹⁵N labeling).
2. Key enzymes: Helicase (unwinds), Primase (makes RNA primer), DNA Polymerase (extends 5'→3', proofreads with 3'→5' exonuclease), DNA Ligase (seals nicks), Topoisomerase (relieves supercoiling).
3. Leading vs lagging strand: Leading = continuous synthesis toward fork. Lagging = Okazaki fragments away from fork, each needing a primer. Both synthesized 5'→3'.
4. Fidelity: Raw error 1/10⁵ → proofreading → 1/10⁷ → mismatch repair → 1/10⁹–10¹⁰.
5. Telomeres: TTAGGG repeats. Shortened each division → Hayflick limit → senescence. Telomerase extends telomeres — active in germline, stem cells, and ~90% of cancers.
⚠️ The Most Common Replication Mistakes
DNA polymerase synthesizes 5'→3' — it reads the template 3'→5'. Students confuse the direction of synthesis with the direction of template reading. The new strand is synthesized 5'→3' (nucleotides added to the 3'-OH end). The template is read in the 3'→5' direction. These are the same event described from different perspectives — the enzyme moves along the template in the 3'→5' direction and builds the new strand in the 5'→3' direction.
The lagging strand is synthesized in the same overall direction as the leading strand — but discontinuously. Students think the lagging strand is synthesized in the opposite direction from the leading strand. Both strands are synthesized 5'→3' — the difference is that the lagging strand is made in short fragments because it must be extended away from the fork (the only direction that allows 5'→3' synthesis on the antiparallel template). Overall, the lagging strand replication moves with the fork; each individual Okazaki fragment is made opposite to fork movement.
Telomere shortening causes senescence — not death. When telomeres reach a critical length, cells enter senescence (a permanent non-dividing state) or apoptosis — not immediate death. Senescent cells remain metabolically active and actually contribute to aging by secreting inflammatory cytokines (SASP — senescence-associated secretory phenotype) that affect surrounding tissue.
✓ Quick Self-Test
1. What is the semiconservative model of DNA replication?
2. Why does the lagging strand need multiple RNA primers?
3. What is the function of DNA ligase in replication?
4. What is the end replication problem and how is it solved?
5. What is the fidelity of DNA replication and what mechanisms achieve it?
Answers:
1. In semiconservative replication, the two strands of the double helix separate and each serves as a template for synthesis of a new complementary strand. Each resulting daughter molecule consists of one original (parental) strand and one newly synthesized strand. Proved by the Meselson-Stahl experiment using density labeling with ¹⁵N.
2. DNA polymerase can only synthesize DNA in the 5'→3' direction and requires a free 3'-OH to begin extension. The lagging strand template runs in the opposite direction from fork movement (3'→5' relative to fork advance) — so the lagging strand must be synthesized in short fragments (Okazaki fragments) extending away from the fork. Each Okazaki fragment requires its own RNA primer (made by primase) to provide the 3'-OH needed for extension.
3. DNA ligase seals the single-strand nicks (phosphodiester bond breaks) that remain after RNA primers are removed and replaced with DNA during lagging strand synthesis. It covalently joins adjacent Okazaki fragments into a continuous strand by forming the missing phosphodiester bond between the 3'-OH of one fragment and the 5'-phosphate of the next.
4. The end replication problem: DNA polymerase cannot replicate the very end of the lagging strand — when the terminal RNA primer is removed, there is no upstream 3'-OH to fill the gap, so the chromosome becomes slightly shorter with each division. Solved by telomerase — a reverse transcriptase that uses its own RNA template to extend the 3' end of the chromosome (the G-rich strand), allowing the complementary strand to be completed and preventing essential coding sequences from being eroded.
5. Final fidelity is approximately 1 error per 10⁹–10¹⁰ base pairs. Achieved by three mechanisms: (1) Nucleotide selection by DNA polymerase — correct base pairing is thermodynamically favored (~1/10⁵ raw error rate). (2) Proofreading — DNA polymerase's 3'→5' exonuclease detects and excises misincorporated nucleotides (~100-fold improvement to ~1/10⁷). (3) Mismatch repair — post-replication system recognizes mismatch base pairs and repairs them (~100-fold improvement to ~1/10⁹).